Mabpharm Limited (HKG:2181)
0.4800
+0.0300 (6.67%)
May 7, 2026, 3:59 PM HKT
Mabpharm Employees
Mabpharm had 383 employees as of June 30, 2025. The number of employees increased by 68 or 21.59% since the number was reported on December 31, 2024.
Employees
383
Change
68
Growth
21.59%
Revenue / Employee
1.85M HKD
Profits / Employee
163.44K HKD
Market Cap
1.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 383 | 68 | 21.59% |
| Dec 31, 2024 | 315 | -32 | -9.22% |
| Dec 31, 2023 | 347 | -70 | -16.79% |
| Dec 31, 2022 | 417 | -67 | -13.84% |
| Dec 31, 2021 | 484 | 148 | 44.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,794 |
| Frontage Holdings | 1,523 |
| AIM Vaccine | 1,466 |
| Cutia Therapeutics | 304 |
| Zhaoke Ophthalmology | 276 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 202 |
| Beijing Biostar Pharmaceuticals | 131 |
| Kintor Pharmaceutical | 123 |